• BioMar raised 2026 guidance on stronger demand momentum, raw material volatility management, higher marine ingredient prices, favorable biological conditions.
• Volume outlook lifted to 1,630-1,700 thousand tonnes from 1,600-1,670 thousand tonnes.
• Revenue forecast increased to DKK 17-18 billion from DKK 16-17 billion, reflecting higher volumes, raw material prices, current exchange rates.
• EBIT now seen at DKK 1.2-1.3 billion versus DKK 1.1-1.2 billion on improved mix, higher-value nutritional solutions.
• CAPEX view tightened to DKK 400-500 million from DKK 300-500 million, citing progress on Ecuador capacity expansion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioMar Group A/S published the original content used to generate this news brief on August 12, 2026, and is solely responsible for the information contained therein.